This site is intended for managed care professionals in the U.S.
Professionals in Canada should visit CanadaCGM.com
Source:
Key Takeaway: Diabetes care is a superb example of the confluence of the pandemic and heightened importance of technology in changing care delivery and maximizing outcomes despite macro challenges. One technology that has shown to be helpful during the pandemic is Real-Time CGM (rtCGM).
This review highlights:
1) evidence suggesting rtCGM helps individuals in the community manage their diabetes during lockdown;
2) how rtCGM is being used for telehealth to help clinics remotely manage their patients;
3) how rtCGM is being used in hospitals to monitor patient glucose levels and limit health care provider exposure to COVID-19.
The use of rtCGM may also have a protective effect on patients with diabetes to help mitigate the severity of COVID-19 by helping to optimize glycemic control. One critical and lasting consequence of the pandemic will be the accelerated adoption of digital technology in healthcare delivery.
Source: Diabetes Technology & Therapeutics
Key Takeaway: The present case reports illustrate how telemedicine can be used safely and effectively for new-onset T1D training and education for both pediatric and adult patients and their families. The COVID-19 pandemic has acutely stimulated the expansion of the use of telemedicine and digital medicine. We conclude that telemedicine is an effective approach for the management of patients with new-onset T1D.
Source: Diabetes Technology & Therapeutics
Key Takeaway: Acute diabetes complication like DKA increases morbidity and mortality in addition to adding cost to the health care system. The current pandemic of COVID-19 has allowed newer ways (with the help of newer technologies) to manage high-risk patients with T1D and DKA through telehealth and may result in lasting benefits to people with T1D.
This web site is supported by an educational grant from DexCom, Inc.